272 related articles for article (PubMed ID: 2894891)
1. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
3. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
4. Separation of transforming growth factors TGF alpha and TGF beta during chromatographic purification of extracts from mouse C-234 tumors.
Popik W
Arch Immunol Ther Exp (Warsz); 1987; 35(6):839-51. PubMed ID: 3508041
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factors in solid human malignant neoplasms.
Nickell KA; Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
[TBL] [Abstract][Full Text] [Related]
6. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
Twardzik DR; Sherwin SA
J Cell Biochem; 1985; 28(4):289-97. PubMed ID: 2997242
[TBL] [Abstract][Full Text] [Related]
8. Partial purification of transforming growth factors from human milk.
Zwiebel JA; Bano M; Nexo E; Salomon DS; Kidwell WR
Cancer Res; 1986 Feb; 46(2):933-9. PubMed ID: 3000589
[TBL] [Abstract][Full Text] [Related]
9. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
11. Growth factor production by human colon carcinoma cell lines.
Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
[TBL] [Abstract][Full Text] [Related]
12. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
13. Latent transformed growth-inhibiting factor in human malignant effusions.
Podolsky DK; Pleskow DK; Jafari H
Cancer Res; 1988 Jan; 48(2):418-24. PubMed ID: 3257164
[TBL] [Abstract][Full Text] [Related]
14. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
Zwiebel JA; Davis MR; Kohn E; Salomon DS; Kidwell WR
Cancer Res; 1982 Dec; 42(12):5117-25. PubMed ID: 6291748
[TBL] [Abstract][Full Text] [Related]
15. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
Tucker RF; Volkenant ME; Branum EL; Moses HL
Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
[TBL] [Abstract][Full Text] [Related]
19. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
Jullien P; Berg TM; de Lannoy C; Lawrence DA
J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
